https://orcid.org/0000-0001-7555-7311
References
- Sartor Z, Kesey J, Dissanaike S. The effects of intravenous vitamin C on point-of-care glucose monitoring. J Burn Care Res. 2015;36(1):50–56.
- Kim SK, Hahm JR, Kim HS, et al. Spurious elevation of glucose concentration during administration of high dose of ascorbic acid in a patient with type 2 diabetes on hemodialysis. Yonsei Med J. 2013;54(5):1289–1292.
- Corl DG, Lucy Hoofnagle, et al. Measuring point-of-care blood glucose in critically ill patients: FDA standards call for accuracy in devices. Nursing Crit Care. 2015;10:22–31.
- Tang Z, Du X, Louie RF, et al. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am J Clin Pathol. 2000;113(1):75–86.
- Floré KM, Delanghe JR. Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: an overview. Perit Dial Int. 2009;29(4):377–383.
- Orija IB, Zahid SH. Pseudohyperglycemia secondary to high-dose intravenous vitamin C managed as diabetic ketoacidosis: an endocrinological catastrophe. AACE Clin Case Rep. 2020;7(4):239–242.
- Tran NK, Godwin ZR, Steele AN, et al. Clinical impact of accurate point-of-Care glucose monitoring for tight glycemic control in severely burned children. Pediatr Crit Care Med. 2016;17(9):e406–12.